Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CANbridge Pharmaceuticals Inc. ( (HK:1228) ) has shared an update.
CANbridge Pharmaceuticals Inc. has announced that its annual general meeting (AGM) will be held virtually on June 27, 2025. The meeting will cover several key resolutions, including the re-election of board members, the re-appointment of the company’s auditor, and the authorization for directors to issue additional shares. These decisions are crucial for the company’s governance and financial strategies, potentially impacting its market operations and shareholder value.
More about CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapies for rare diseases and targeted cancers.
Average Trading Volume: 2,079,050
Technical Sentiment Signal: Sell
Current Market Cap: HK$66.7M
Find detailed analytics on 1228 stock on TipRanks’ Stock Analysis page.